Infinity Announces the Date of Its Fourth Quarter and Full Year 2017 Financial Results Conference Call and Webcast

March 8, 2018 at 4:05 PM EST

CAMBRIDGE, Mass., March 8, 2018 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Thursday, March 15, 2018, at 4:30 p.m. ET to review its fourth quarter and full year 2017 financial results and provide an update on the company.

A live webcast of the conference call can be accessed in the Investors/Media section of Infinity's website at To participate in the conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526 (international) five minutes prior to start time. The conference ID number is 5558799. An archived version of the webcast will be available on Infinity's website for 30 days.

About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at

Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or

Cision View original content:

SOURCE Infinity Pharmaceuticals, Inc.